Hanover, MD, July 25, 2022 – The Society for Clinical Research Sites (SCRS) today announced the Sponsor and CRO finalists for the 2022 SCRS Eagle Award. The Eagle Award recognizes CROs and Sponsors that have shown outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.
The finalists were selected from nominations provided by clinical research sites around the world. Voting is now open to all clinical research site professionals and closes on August 26, 2022.
The 2022 Sponsor nominees are: Eli Lilly, Janssen, the Pharmaceutical Companies of Johnson & Johnson, Merck, Moderna, Novartis, Pfizer and Roche
The 2022 CRO nominees are: ICON plc, IQVIA, Labcorp, Parexel, PPD, and Syneos Health
Sean Soth, SCRS Senior Vice President of Strategy & Global Business Partnerships commented, “As SCRS celebrates 10 years of advancing site success, what the Eagle Award represents has been an integral component to that mission. Effective partnerships and collaboration between sites and the organizations they work with impacts site sustainability as well as our patients. SCRS congratulates the 2022 finalists and looks forward to honoring the recipients at the 2022 Global Site Solutions Summit.”
About The Society for Clinical Research Sites
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.
Society for Clinical Research Sites